Torrent Pharma Q4 results: Profit at Rs 287 crore, board announces 160% dividend

Torrent Pharma on Tuesday reported a net profit of Rs 287 crore for the quarter ended March 2023, as against a net loss of Rs 118 crore for the corresponding period a year ago. The board of the Gujarat-based pharma company recommended a dividend of Rs 8 per share, subject to shareholders' approval. 

Torrent Pharma Q4 results 

Torrent Pharma's revenue came in at Rs 2,491 crore for the three-month period, as against Rs 2,131 crore for the year-ago period, according to a regulatory filing. 

The company reported a 29.6 per cent year-on-year increase in earnings before interest, taxes, depreciation and ammortisation (EBITDA) to Rs 727 crore, including a one-off charge of Rs 10 crore. 

Its spending towards research and development was at Rs 150 crore for the final three months of the financial year 2022-23, as against Rs 138 crore for the year-ago period. 

The company said its EBITDA margin stood at 29.2 per cent. 

Torrent Pharma dividend

Torrent Pharma's board recommended a dividend of Rs 8 per share — a 160 per cent payout given the face value of Rs 5 per share, a final dividend for the financial year ended March 2023.   

Torrent Pharma shares ended 0.7 per cent higher at Rs 1,717.2 apiece on BSE ahead of the earnings announcement.

Torrent Pharma dividend: When will the payment be made? 

The dividend will be paid or dispatched on or around August 14, 2023, according to the company.

In February, Torrent Pharma had paid an interim dividend of Rs 14 (a 280 per cent payout) for the previous quarter. 

Torrent Pharma shares: Past performance 

Torrent Pharma shares finished the March quarter with a decline of 0.9 per cent, better than a 4.1 per cent fall in the benchmark Nifty index. 

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.